Southwest Family Health Centre is a group of dedicated Family Physicians, Psychiatrist, Mental Health Counselors, Registered Dietitian, and a Clinical Pharmacist serving patients in the downtown Hamilton and surrounding areas. As part of the Hamilton Family Health Team we offer patients a wide variety of additional services and support. Our goal is to provide exceptional and timely health care to our patients.
Covid-19 Vaccine Patient Information:
COVID-19 VACCINATION NOW AVAILABLE FOR PATIENTS 5 YEARS AND OLDER
To book an appointment with Southwest Family Health Centre, please call our main line at 905-526-1606 outside of high-volume phone times of 9 am to 10 am and 1:15 pm to 2 pm.
For more COVID-19 resources and information
--- January 10, 2022 ---
Southwest Family Health Centre is pleased to announce that we are offering Covid vaccinations and boosters in clinic. We currently have supply of Pfizer, both adult and pediatric, and Moderna.
You may book an appointment by calling our main line at 905-526-1606. We ask that you call outside of high-volume phone times of 9 am to 10 am and 1:15 to 2 pm.
Eligibility as of January 2022:
First and second doses:
5- to 11-year-olds:
Individuals born in 2016 or earlier
Individuals can get vaccinated after they turn 5 years old
NACI recommends a minimum of 8 weeks between first and second dose, however it is possible to give 21 days after first dose based on parent preference
12 years of age or older:
Individuals born in 2009 or earlier who are age 12 and older
Second dose must be 8 weeks after first dose
18 years of age or older:
Individuals aged 18 and older
Booster dose, minimum of 3 months (84 days) after second dose
Third dose, minimum of 8 weeks (56 days) after second dose
Individuals with stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome
Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
Individuals receiving active treatment (including those who have completed treatment within the last three months) for solid tumour or hematologic malignancies (e.g.: chemotherapy, targeted therapies, immunotherapy)
Recipients of solid-organ transplant and taking immunosuppressive therapy
Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
Individuals receiving active treatment with the following categories of immunosuppressive therapies, anti-B cell therapies such as monoclonal antibodies targeting CD19, CD20 and CD22 (including those who have completed treatment within 12 months), high dose corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor inhibitors and other biologic agents that are significantly immunosuppressive
Individuals receiving dialysis (hemodialysis or peritoneal dialysis)